On June 24, 2018, the United States Pharmacopeia (USP) and the Coalition for PET Drugs co-sponsored a session at the 2018 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in Philadelphia. The session was entitled “USP Radiopharmaceutical Updates.” The session focused on various topics relevant to academic and commercial PET drug manufacturers. The session was co-organized by Ravi Ravichandran, Ph.D., Sally Schwarz, R.Ph., and Steve Zigler, Ph.D. Sally Schwarz moderated the session. The session drew approximately 125 attendees representing academic PET drug manufacturers, commercial PET drug manufacturers, FDA representatives, and others.

The presentations from the session are available here:

1. Overview of USP activities and How to get Involved – Ravi Ravichandran, Ph.D.
2. Current and Future USP Initiatives for Radiopharmaceuticals – Steve Zigler, Ph.D.
3. Introduction to USP Chapter General Chapter – Paul Mahan, R.Ph.